| ALN | Program Name | Expenditures |
|---|---|---|
| 93.RD | Multivalent Flavivirus Vaccine Development Using a Flexible Replication RNA Platform | $2.78M |
| 93.RD | Advanced Development and Clinical Evaluation of a Synthetic Intranasal Entamoeba Histolytica Vaccine Containing Adjuvant | $1.34M |
| 93.RD | Development of Vaccine Candidates for Biodefenses, AMR Infections and Emerging Infectious Diseases | $1.32M |
| 12.420 | MILITARY MEDICAL RESEARCH AND DEVELOPMENT | $50,523 |
| 93.RD | Adjuvant Discovery Program | $47,422 |
| 93.855 | ALLERGY AND INFECTIOUS DISEASES RESEARCH | $9,244 |